BackAscelia Pharma AB (publ) Overview

Ascelia Pharma AB (publ) Total Liabilities

Ascelia Pharma AB (publ)'s total liabilities is $10M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$10.40M
↓ 67.11% YoYΔ $-21.22M vs prior year quarter

Peer trimmed avg / median

Loading

Ascelia Pharma AB (publ) Total Liabilities History

Loading

Ascelia Pharma AB (publ) vs. peers: Total Liabilities Comparison

Loading

Ascelia Pharma AB (publ) Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ascelia Pharma AB (publ) (ACE.ST) FAQ

As of the most recent data (June 2026), ACE.ST shows a total liabilities of $10M. That compares with $32M in the prior-year period — down 67.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ACE.ST's total liabilities is now $10M (was $32M) — a 67.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ascelia Pharma AB (publ) is outperforming or lagging.

Tracking ACE.ST's total liabilities over time shows whether Ascelia Pharma AB (publ) is scaling, shrinking, or reshaping that part of the business. The current reading is $10M That compares with $32M in the prior-year period — down 67.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Ascelia Pharma AB (publ)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $10M) with ownership activity and broader fundamentals.

Ascelia Pharma AB (publ)'s total liabilities is $10M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.